Authors
Seppo Meri, Vesa Koistinen, A Miettinen, T Törnroth, IJ Seppälä
Publication date
1992/4/1
Journal
Journal of Experimental Medicine
Volume
175
Issue
4
Pages
939-950
Publisher
Rockefeller University Press
Description
Immunopathological evidence suggests that activation of the alternative pathway of complement (AP) is involved in membranoproliferative glomerulonephritis (MPGN) and in immunoglobulin A nephropathy. In this report we describe an AP dysfunction-associated factor that was isolated from the serum and urine of a patient with hypocomplementemic MPGN. Extensive glomerular deposits of C3, properdin, and of the terminal complement components were observed in the kidney of the patient. In her serum the AP hemolytic activity was virtually absent. When mixed with fresh normal serum, the patient's serum induced a 96% C3 conversion during a 30-min incubation at +37 degrees C. This activity was found to be due to a circulating factor that by immunochemical characterization proved to be a 46-kD monoclonal immunoglobulin lambda light (L) chain dimer (lambda L). Purified lambda L, but not control lambda or …
Total citations
19941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320245322471672421288610710111313209131811151296
Scholar articles